Anne Cooper

989 total citations
20 papers, 724 citations indexed

About

Anne Cooper is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anne Cooper has authored 20 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anne Cooper's work include Drug Transport and Resistance Mechanisms (6 papers), Chemokine receptors and signaling (4 papers) and Inhalation and Respiratory Drug Delivery (3 papers). Anne Cooper is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), Chemokine receptors and signaling (4 papers) and Inhalation and Respiratory Drug Delivery (3 papers). Anne Cooper collaborates with scholars based in United Kingdom, United States and Sweden. Anne Cooper's co-authors include Ken Grime, Charles D. Surh, Ross L. Coppel, Rolland E. Dickson, Barry H. Hirst, Douglas Ferguson, Vanessa Moore, Aftab A. Ansari, M. Eric Gershwin and Dean J. Danner and has published in prestigious journals such as New England Journal of Medicine, Hepatology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Anne Cooper

20 papers receiving 704 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Cooper United Kingdom 13 211 169 168 155 86 20 724
Daniela Passeri Italy 19 381 1.8× 165 1.0× 80 0.5× 527 3.4× 79 0.9× 40 1.1k
Bradley T. Keller United States 16 357 1.7× 193 1.1× 102 0.6× 212 1.4× 29 0.3× 21 764
TORU KOMAI United Kingdom 17 164 0.8× 87 0.5× 92 0.5× 214 1.4× 20 0.2× 45 790
Joseph L. Skibba United States 21 165 0.8× 92 0.5× 134 0.8× 298 1.9× 75 0.9× 34 892
Debra L. Williams United States 11 144 0.7× 132 0.8× 125 0.7× 241 1.6× 56 0.7× 15 1.0k
N.R. Kitteringham United Kingdom 20 250 1.2× 73 0.4× 48 0.3× 281 1.8× 57 0.7× 33 971
Xiao-bo Zhong United States 12 274 1.3× 139 0.8× 94 0.6× 567 3.7× 38 0.4× 13 1.3k
Vikram Kansra United States 19 346 1.6× 94 0.6× 82 0.5× 415 2.7× 146 1.7× 52 1.2k
Marion Ganslmayer Germany 14 153 0.7× 107 0.6× 115 0.7× 433 2.8× 64 0.7× 37 802
Scott Martin United Kingdom 15 193 0.9× 142 0.8× 191 1.1× 407 2.6× 82 1.0× 32 955

Countries citing papers authored by Anne Cooper

Since Specialization
Citations

This map shows the geographic impact of Anne Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Cooper more than expected).

Fields of papers citing papers by Anne Cooper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Cooper. The network helps show where Anne Cooper may publish in the future.

Co-authorship network of co-authors of Anne Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Cooper. A scholar is included among the top collaborators of Anne Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Cooper. Anne Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bennett, K.A., Eugenia Sergeev, Cliona MacSweeney, Geor Bakker, & Anne Cooper. (2021). Understanding Exposure-Receptor Occupancy Relationships for Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators across a Range of Preclinical and Clinical Studies. Journal of Pharmacology and Experimental Therapeutics. 377(1). 157–168. 3 indexed citations
2.
Hutter, Victoria, David Chau, Constanze Hilgendorf, et al.. (2013). Digoxin net secretory transport in bronchial epithelial cell layers is not exclusively mediated by P-glycoprotein/MDR1. European Journal of Pharmaceutics and Biopharmaceutics. 86(1). 74–82. 10 indexed citations
3.
Brady, Roscoe O., Anne Cooper, Neeraj Tandon, et al.. (2012). A longitudinal pilot proton MRS investigation of the manic and euthymic states of bipolar disorder. Translational Psychiatry. 2(9). e160–e160. 33 indexed citations
4.
Hutter, Victoria, et al.. (2012). Evaluation of layers of the rat airway epithelial cell line RL-65 for permeability screening of inhaled drug candidates. European Journal of Pharmaceutical Sciences. 47(2). 481–489. 3 indexed citations
5.
Cooper, Anne, Douglas Ferguson, & Ken Grime. (2012). Optimisation of DMPK by the Inhaled Route: Challenges and Approaches. Current Drug Metabolism. 13(4). 457–473. 78 indexed citations
6.
Fellows, Michael, Tim Luker, Anne Cooper, & Michael R. O’Donovan. (2012). Unusual structure–genotoxicity relationship in mouse lymphoma cells observed with a series of kinase inhibitors. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 746(1). 21–28. 5 indexed citations
7.
8.
Cumming, John G., S Brown, Anne Cooper, et al.. (2006). Modulators of the human CCR5 receptor. Part 3: SAR of substituted 1-[3-(4-methanesulfonylphenyl)-3-phenylpropyl]-piperidinyl phenylacetamides. Bioorganic & Medicinal Chemistry Letters. 16(13). 3533–3536. 15 indexed citations
9.
Cumming, John G., Anne Cooper, Ken Grime, et al.. (2005). Modulators of the human CCR5 receptor. Part 2: SAR of substituted 1-(3,3-diphenylpropyl)-piperidinyl phenylacetamides. Bioorganic & Medicinal Chemistry Letters. 15(22). 5012–5015. 21 indexed citations
10.
Baxter, Andrew, et al.. (2005). Hit-to-Lead studies: The discovery of potent, orally bioavailable thiazolopyrimidine CXCR2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 16(4). 960–963. 44 indexed citations
11.
Cooper, Anne, et al.. (2004). Differential Multidrug Resistance-Associated Protein 1 through 6 Isoform Expression and Function in Human Intestinal Epithelial Caco-2 Cells. Journal of Pharmacology and Experimental Therapeutics. 311(2). 476–484. 116 indexed citations
12.
Cooper, Anne, et al.. (2004). P-glycoprotein Potentiates CYP3A4-mediated Drug Disappearance during Caco-2 Intestinal Secretory Detoxification. Journal of drug targeting. 12(7). 405–413. 19 indexed citations
13.
Baxter, Andrew, Anne Cooper, Eike Floettmann, et al.. (2004). Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(11). 2817–2822. 70 indexed citations
14.
Baxter, Andrew, Anne Cooper, Nicholas D. Kindon, et al.. (2003). Hit-to-Lead studies: The discovery of potent, orally bioavailable triazolethiol CXCR2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(16). 2625–2628. 31 indexed citations
15.
Riley, Robert J., Iain Martin, & Anne Cooper. (2002). The Influence of DMPK as an Integrated Partner in Modern Drug Discovery. Current Drug Metabolism. 3(5). 527–550. 24 indexed citations
16.
Cooper, Anne, et al.. (1996). Excretion and metabolism of tipredane, a novel glucocorticoid, in the rat, mouse, monkey, and human.. Drug Metabolism and Disposition. 24(10). 1071–1080. 5 indexed citations
17.
Riley, Robert J., et al.. (1995). Induction of rodent hepatic drug-metabolizing enzyme activities by the novel anticonvulsant remacemide hydrochloride.. Drug Metabolism and Disposition. 23(9). 922–928. 5 indexed citations
18.
Carr, Richard D., et al.. (1990). Preferential biliary elimination of FPL 63547, a novel inhibitor of angiotensin‐converting enzyme, in the rat. British Journal of Pharmacology. 100(1). 90–94. 7 indexed citations
19.
Water, Judy Van de, Anne Cooper, Charles D. Surh, et al.. (1989). Detection of Autoantibodies to Recombinant Mitochondrial Proteins in Patients with Primary Biliary Cirrhosis. New England Journal of Medicine. 320(21). 1377–1380. 161 indexed citations
20.
Surh, Charles D., Anne Cooper, Ross L. Coppel, et al.. (1988). The predominance of IgG3 and IgM isotype antimitochondrial autoantibodies against recombinant fused mitochondrial polypeptide in patients with primary biliary cirrhosis. Hepatology. 8(2). 290–295. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniela Passeri Breakdown of academic impact, for papers by Bradley T. Keller Breakdown of academic impact, for papers by TORU KOMAI Breakdown of academic impact, for papers by Joseph L. Skibba Breakdown of academic impact, for papers by Debra L. Williams Breakdown of academic impact, for papers by N.R. Kitteringham Breakdown of academic impact, for papers by Xiao-bo Zhong Breakdown of academic impact, for papers by Vikram Kansra Breakdown of academic impact, for papers by Marion Ganslmayer Breakdown of academic impact, for papers by Scott Martin
Rankless by CCL
2026